Hall Private Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Hall Private Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,352	Closed	-$335K	–	42
2023 Q2	$335K	Sell	4,352 -108,908	-96%	-$8.69M	0.18%	37
2023 Q1	$9.4M	Sell	113,260 -14,824	-12%	-$1.23M	4.9%	6
2022 Q4	$11M	Sell	128,084 -22,019	-15%	-$1.74M	6.25%	3
2022 Q3	$9.26M	Sell	150,103 -10,057	-6%	-$634K	5.33%	6
2022 Q2	$9.9M	Buy	160,160 +15,998	+11%	+$990K	5.56%	7
2022 Q1	$8.57M	Buy	144,162 +16,684	+13%	+$1.07M	4.58%	9
2021 Q4	$9.26M	Buy	127,478 +12,403	+11%	+$854K	5.75%	7
2021 Q3	$8.04M	Buy	115,075 +59,520	+107%	+$4.18M	5.13%	5
2021 Q2	$3.83M	Buy	+55,555	New	+$3.71M	2.49%	15
2020 Q4	$1.18M	Buy	+20,199	New	+$1.22M	0.97%	26

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hall Private Wealth Advisors's GILD Position: Q3 2023 in Review

Hall Private Wealth Advisors sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 4,352 shares — an estimated $335K sold.

Hall Private Wealth Advisors first reported a position in GILD in Q4 2020 and held it in 10 quarters. The position peaked at $11M in Q4 2022. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Hall Private Wealth Advisors reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Hall Private Wealth Advisors sold 4,352 Gilead Sciences shares in Q3 2023, an estimated $335K.
Hall Private Wealth Advisors first reported a position in Gilead Sciences in Q4 2020 and held it in 10 quarters.
Hall Private Wealth Advisors's Gilead Sciences position peaked at $11M in Q4 2022.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Hall Private Wealth Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.